GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Research & Development

DuChemBio Co (XKRX:176750) Research & Development : ₩205 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. DuChemBio Co's Research & Development for the six months ended in Dec. 2023 was ₩205 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩205 Mil.


DuChemBio Co Research & Development Historical Data

The historical data trend for DuChemBio Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Research & Development Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 1,885.79 1,710.59 171.67 17.53 205.31

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development Get a 7-Day Free Trial 1,885.79 1,710.59 171.67 17.53 205.31

DuChemBio Co Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩205 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DuChemBio Co  (XKRX:176750) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


DuChemBio Co Research & Development Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


DuChemBio Co (XKRX:176750) Business Description

Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines